Literature DB >> 21880013

Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis.

Maria Klaude1, Maiko Mori, Inga Tjäder, Thomas Gustafsson, Jan Wernerman, Olav Rooyackers.   

Abstract

Muscle wasting negatively affects morbidity and mortality in critically ill patients. This progressive wasting is accompanied by, in general, a normal muscle PS (protein synthesis) rate. In the present study, we investigated whether muscle protein degradation is increased in critically ill patients with sepsis and which proteolytic enzyme systems are involved in this degradation. Eight patients and seven healthy volunteers were studied. In vivo muscle protein kinetics was measured using arteriovenous balance techniques with stable isotope tracers. The activities of the major proteolytic enzyme systems were analysed in combination with mRNA expression of genes related to these proteolytic systems. Results show that critically ill patients with sepsis have a variable but normal muscle PS rate, whereas protein degradation rates are dramatically increased (up to 160%). Of the major proteolytic enzyme systems both the proteasome and the lysosomal systems had higher activities in the patients, whereas calpain and caspase activities were not changed. Gene expression of several genes related to the proteasome system was increased in the patients. mRNA levels of the two main lysosomal enzymes (cathepsin B and L) were not changed but, conversely, genes related to calpain and caspase had a higher expression in the muscles of the patients. In conclusion, the dramatic muscle wasting seen in critically ill patients with sepsis is due to increased protein degradation. This is facilitated by increased activities of both the proteasome and lysosomal proteolytic systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21880013     DOI: 10.1042/CS20110233

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  47 in total

1.  β-hydroxy-β-methylbutyrate (HMB) prevents sepsis-induced diaphragm dysfunction in mice.

Authors:  Gerald S Supinski; Leigh A Callahan
Journal:  Respir Physiol Neurobiol       Date:  2014-03-12       Impact factor: 1.931

2.  Inhibition of jejunal protein synthesis and breakdown in Pseudomonas aeruginosa-induced sepsis pig model.

Authors:  Gabriëlla A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-04-12       Impact factor: 4.052

3.  Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis.

Authors:  Brian T O'Neill; Kevin Y Lee; Katherine Klaus; Samir Softic; Megan T Krumpoch; Joachim Fentz; Kristin I Stanford; Matthew M Robinson; Weikang Cai; Andre Kleinridders; Renata O Pereira; Michael F Hirshman; E Dale Abel; Domenico Accili; Laurie J Goodyear; K Sreekumaran Nair; C Ronald Kahn
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

4.  Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation.

Authors:  Gerald S Supinski; Alexander P Alimov; Lin Wang; Xiao-Hong Song; Leigh A Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-02       Impact factor: 5.464

Review 5.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

6.  Muscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis.

Authors:  Gerald S Supinski; Lin Wang; Xiao-Hong Song; Jennifer S Moylan; Leigh Ann Callahan
Journal:  J Appl Physiol (1985)       Date:  2014-08-28

Review 7.  Sarcopenia in critically ill patients.

Authors:  Muhammet C Kizilarslanoglu; Mehmet E Kuyumcu; Yusuf Yesil; Meltem Halil
Journal:  J Anesth       Date:  2016-07-04       Impact factor: 2.078

Review 8.  Metabolic Inflammatory Complex in Sepsis: Septic Cachexia as a Novel Potential Therapeutic Target.

Authors:  Masao Kaneki
Journal:  Shock       Date:  2017-12       Impact factor: 3.454

9.  Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice.

Authors:  Masayuki Kobayashi; Shingo Kasamatsu; Shohei Shinozaki; Shingo Yasuhara; Masao Kaneki
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

10.  Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.

Authors:  Tobias Wollersheim; Janine Woehlecke; Martin Krebs; Jida Hamati; Doerte Lodka; Anja Luther-Schroeder; Claudia Langhans; Kurt Haas; Theresa Radtke; Christian Kleber; Claudia Spies; Siegfried Labeit; Markus Schuelke; Simone Spuler; Joachim Spranger; Steffen Weber-Carstens; Jens Fielitz
Journal:  Intensive Care Med       Date:  2014-02-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.